Skip to main navigation
Skip to search
Skip to main content
Maastricht University Home
Support & FAQ
Home
Researchers
Publications
Activities
Press/Media
Prizes
Organisations
Dataset/Software
Projects
Search by expertise, name or affiliation
Phase 1 Clinical Trials in Psychopharmacology
Eef Theunissen
*
*
Corresponding author for this work
Section Psychopharmacology
Psychopharmacology
Research output
:
Chapter in Book/Report/Conference proceeding
›
Chapter
›
Academic
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Phase 1 Clinical Trials in Psychopharmacology'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Phase 1 Trial
100%
Psychopharmacology
100%
Phase 1 Clinical Trial
100%
Clinical Trials
33%
Design Methodology
33%
Health Authorities
33%
European Union
33%
Drug Development
33%
Ethical Committee
33%
Clinical Development
33%
Dose-ranging
33%
Effective Dose
33%
Human Participants
33%
Design Organization
33%
Safe Dose
33%
Objective Design
33%
Conductive Phase
33%
Clinical Trial Application
33%
INIS
clinical trials
100%
guidelines
100%
drugs
50%
applications
25%
humans
25%
risks
25%
regulations
25%
design
25%
range
25%
european union
25%
effective doses
25%
Pharmacology, Toxicology and Pharmaceutical Science
Clinical Trial
100%
Psychopharmacology
100%
Drug Development
33%